Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

19 structures for O60701

Entry ID Method Resolution Chain Position Source
2Q3E X-ray 200 A A/B/C/D/E/F/G/H/I/J/K/L 1-466 PDB
2QG4 X-ray 210 A A/B/C/D/E/F/G/H 1-466 PDB
3ITK X-ray 240 A A/B/C/D/E/F 1-466 PDB
3KHU X-ray 230 A A/B/C/D/E/F 1-466 PDB
3PRJ X-ray 310 A A/B/C/D/E/F 1-494 PDB
3PTZ X-ray 250 A A/B/C/D/E/F 1-494 PDB
3TDK X-ray 280 A A/B/C/D/E/F/G/H/I/J/K/L 1-487 PDB
3TF5 X-ray 230 A A/B/C 1-494 PDB
4EDF X-ray 208 A A/B/C/D 1-494 PDB
4RJT X-ray 270 A A/B/C 1-494 PDB
5TJH X-ray 205 A A/B/C/D/E/F 1-494 PDB
5VR8 X-ray 200 A A/B/C/D/E/F 1-494 PDB
5W4X X-ray 265 A A/B/C 1-466 PDB
6C4J X-ray 253 A A/B/C/D/E/F/G/H/I/J/K/L 1-494 PDB
6C4K X-ray 265 A A/B/C 1-494 PDB
6C58 X-ray 220 A A/B/C/D/E/F 1-494 PDB
6C5A X-ray 230 A A/B/C/D/E/F 1-494 PDB
6C5Z X-ray 295 A A/B/C/D/E/F 1-494 PDB
AF-O60701-F1 Predicted AlphaFoldDB

319 variants for O60701

Variant ID(s) Position Change Description Diseaes Association Provenance
CA2895248
RCV000999493
VAR_083750
RCV001004652
rs369608407
14 Y>C Variant assessed as Somatic; 0.0 impact. Developmental and epileptic encephalopathy, 84 DEE84 [NCI-TCGA, ClinVar, UniProt] Yes ClinGen
ClinVar
ESP
ExAC
NCI-TCGA
dbSNP
gnomAD
UniProt
CA356663116
VAR_083751
RCV000999492
rs1306655122
24 A>T DEE84; unknown pathological significance [UniProt] Yes ClinGen
ClinVar
TOPMed
dbSNP
UniProt
CA356662845
VAR_083752
RCV000999491
rs1578282133
42 I>T DEE84; unknown pathological significance [UniProt] Yes ClinGen
ClinVar
Ensembl
dbSNP
UniProt
CA2895236
RCV001004651
rs749975104
VAR_083753
RCV000999490
44 A>V Developmental and epileptic encephalopathy, 84 DEE84; severely decreased protein stability; decreased hexamer formation; severe decrease of UDP-glucose 6-dehydrogenase activity [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
TOPMed
dbSNP
gnomAD
VAR_083754
RCV001004655
rs200059198
RCV000999489
CA2895209
65 R>missing Developmental and epileptic encephalopathy, 84 DEE84 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
TOPMed
dbSNP
gnomAD
VAR_083754
rs200059198
65 R>del DEE84 [UniProt] Yes UniProt
dbSNP
RCV001004653
rs769243823
CA356661611
RCV000999488
VAR_083755
72 S>A Developmental and epileptic encephalopathy, 84 DEE84 [ClinVar, UniProt] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
UniProt
RCV000999487
rs1578274054
RCV001004654
VAR_083756
CA356661543
82 A>T Developmental and epileptic encephalopathy, 84 DEE84; decreased function in glycosaminoglycan biosynthetic process in patient cells; severely decreased protein stability; decreased hexamer formation; severe decrease of UDP-glucose 6-dehydrogenase activity [ClinVar, UniProt] Yes ClinGen
ClinVar
Ensembl
dbSNP
UniProt
VAR_083757
rs903919278
CA95713116
116 I>T DEE84; unknown pathological significance [UniProt] Yes ClinGen
Ensembl
UniProt
rs1381665298
CA356660872
RCV000999485
VAR_083758
155 Q>missing DEE84 [UniProt] Yes ClinGen
ClinVar
UniProt
dbSNP
gnomAD
rs1381665298
VAR_083758
155 Q>del DEE84 [UniProt] Yes UniProt
dbSNP
CA356659299
rs756467468
VAR_083759
RCV000999484
175 P>A DEE84; unknown pathological significance [UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
dbSNP
gnomAD
RCV000999483
rs1578269761
CA356658638
VAR_083760
217 E>D DEE84; unknown pathological significance [UniProt] Yes ClinGen
ClinVar
Ensembl
dbSNP
UniProt
rs1186496501
VAR_083761
RCV000999482
CA356658376
255 I>T DEE84; unknown pathological significance [UniProt] Yes ClinGen
ClinVar
UniProt
dbSNP
gnomAD
VAR_083762
CA356658268
rs1578269200
RCV000999481
271 G>R DEE84; unknown pathological significance [UniProt] Yes ClinGen
ClinVar
Ensembl
dbSNP
UniProt
CA356656338
RCV000999480
rs1578265068
VAR_083763
303 V>I DEE84; unknown pathological significance; may affect splicing [UniProt] Yes ClinGen
ClinVar
Ensembl
dbSNP
UniProt
CA356656236
RCV000999479
VAR_083764
rs1578265048
306 M>V DEE84; unknown pathological significance [UniProt] Yes ClinGen
ClinVar
Ensembl
dbSNP
UniProt
RCV000723274
RCV001004657
CA2895036
rs775162839
VAR_083765
317 R>Q Developmental and epileptic encephalopathy, 84 DEE84; unknown pathological significance [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
TOPMed
dbSNP
gnomAD
VAR_083766 356 Y>del DEE84 [UniProt] Yes UniProt
VAR_083767
RCV001004656
CA356654803
RCV000999477
rs1578264574
367 Y>C Developmental and epileptic encephalopathy, 84 DEE84 [ClinVar, UniProt] Yes ClinGen
ClinVar
Ensembl
dbSNP
UniProt
VAR_083768
RCV000999476
RCV003152743
rs113094436
CA2894982
393 R>W Developmental and epileptic encephalopathy, 84 DEE84; unknown pathological significance [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
1000Genomes
ExAC
dbSNP
gnomAD
RCV000999475
CA2894973
VAR_083769
rs770456604
410 A>S DEE84; unknown pathological significance [UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
TOPMed
dbSNP
gnomAD
rs201894374
RCV000999474
VAR_083770
CA95709378
442 R>W DEE84; unknown pathological significance [UniProt] Yes ClinGen
ClinVar
UniProt
1000Genomes
dbSNP
gnomAD
RCV000999473
VAR_083771
CA95709373
COSM1055266
rs1053767552
443 R>H Variant assessed as Somatic; impact. endometrium DEE84; unknown pathological significance [NCI-TCGA, Cosmic, UniProt] Yes ClinGen
cosmic curated
ClinVar
NCI-TCGA
TOPMed
dbSNP
UniProt
rs779324355
VAR_083772
RCV000999472
CA356653535
449 H>R DEE84; unknown pathological significance [UniProt] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
UniProt
TCGA novel 6 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs767490233
CA2895253
6 K>R No ClinGen
ExAC
gnomAD
CA356663346
rs761771847
7 I>F No ClinGen
ExAC
gnomAD
rs761771847
CA2895252
7 I>L No ClinGen
ExAC
gnomAD
rs773970612
CA2895251
9 C>F No ClinGen
ExAC
gnomAD
rs1049953736
CA95718583
10 I>V No ClinGen
Ensembl
rs376996797
CA95718580
11 G>S No ClinGen
Ensembl
CA2895249
rs759610662
13 G>D No ClinGen
ExAC
gnomAD
CA95718556
rs77771795
16 G>* No ClinGen
Ensembl
CA2895244
rs773827332
20 C>Y No ClinGen
ExAC
TOPMed
gnomAD
CA2895243
rs772663434
23 I>V No ClinGen
ExAC
gnomAD
CA356663113
rs1306655122
24 A>S No ClinGen
TOPMed
rs374505735
CA95718545
25 H>R No ClinGen
Ensembl
CA356663081
rs947588957
26 M>K No ClinGen
TOPMed
gnomAD
CA95718544
rs947588957
26 M>T No ClinGen
TOPMed
gnomAD
rs779084607
CA2895241
31 R>K No ClinGen
ExAC
gnomAD
rs1025047581
CA95718542
32 V>I No ClinGen
TOPMed
CA2895240
rs145763615
33 T>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA95718539
rs914739438
33 T>S No ClinGen
Ensembl
CA356662956
rs1299204864
35 V>I No ClinGen
gnomAD
TCGA novel 38 N>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs928688123
CA95718513
38 N>S No ClinGen
TOPMed
gnomAD
rs1578282143
CA356662892
39 E>A No ClinGen
Ensembl
rs1253201158
CA356662827
43 N>S No ClinGen
TOPMed
CA356662779
rs1388970611
46 N>D No ClinGen
gnomAD
TCGA novel 47 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2895232
rs763792474
50 L>V No ClinGen
ExAC
gnomAD
rs762867803
CA2895231
52 I>V No ClinGen
ExAC
gnomAD
rs752500252
CA2895212
55 P>S No ClinGen
ExAC
gnomAD
CA2895211
rs765143424
59 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA95714842
rs879462114
60 V>A No ClinGen
Ensembl
CA2895210
rs760920354
61 V>I No ClinGen
ExAC
gnomAD
CA2895208
rs767697391
65 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs762979242 68 N>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA2895206
rs140219602
69 L>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
rs765734647 72 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs769243823
CA2895204
72 S>P Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 72 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1446226540
CA356661603
73 T>S No ClinGen
gnomAD
CA2895200
rs775776023
74 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA356661585
rs1489618454
76 D>Y No ClinGen
gnomAD
rs751244149
CA95714785
77 D>V No ClinGen
Ensembl
CA2895198
rs745515782
78 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs202020648
CA95714783
79 I>S No ClinGen
Ensembl
CA2895197
rs776324809
79 I>V No ClinGen
ExAC
gnomAD
TCGA novel 81 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1260873652
CA356661523
83 D>G No ClinGen
TOPMed
rs777181206
CA2895195
83 D>H No ClinGen
ExAC
gnomAD
CA2895194
rs777181206
83 D>N No ClinGen
ExAC
gnomAD
CA2895193
rs187460266
85 V>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA356661497
rs187460266
85 V>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1030577318
CA95713149
89 V>M No ClinGen
Ensembl
rs113565151
CA95713148
90 N>S No ClinGen
ExAC
gnomAD
rs113565151
CA2895174
90 N>T No ClinGen
ExAC
gnomAD
rs1389276038
CA356661282
92 P>S No ClinGen
gnomAD
rs1400737927
CA356661275
93 T>R No ClinGen
gnomAD
CA356661265
rs1172635390
94 K>N No ClinGen
gnomAD
TCGA novel 95 T>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2895172
rs375953801
96 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs998132909
CA95713143
97 G>A No ClinGen
Ensembl
rs1428096648
CA356661225
100 K>N No ClinGen
gnomAD
TCGA novel 102 R>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2895169
rs757450293
102 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA2895170
rs779742282
102 R>W No ClinGen
ExAC
gnomAD
rs1420419492
CA356661202
104 A>V No ClinGen
TOPMed
gnomAD
CA2895168
rs751736713
107 K>* No ClinGen
ExAC
gnomAD
rs568964757
CA2895167
111 A>V No ClinGen
1000Genomes
ExAC
gnomAD
rs1578270554
CA356661150
112 C>S No ClinGen
Ensembl
CA2895166
rs140504706
115 R>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
COSM1618803
CA2895164
rs202045254
115 R>H liver [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
CA2895165
rs202045254
115 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1263944470
CA356661122
117 V>L No ClinGen
gnomAD
CA356661112
rs1221194267
118 Q>L No ClinGen
TOPMed
gnomAD
CA356661113
rs1221194267
118 Q>R No ClinGen
TOPMed
gnomAD
CA356661108
rs1371247878
119 N>D No ClinGen
gnomAD
rs766669367
CA2895161
121 N>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs766669367
CA2895162
121 N>H No ClinGen
ExAC
TOPMed
gnomAD
CA356661075
rs1333300842
124 K>E No ClinGen
gnomAD
CA2895160
rs760304916
125 I>M No ClinGen
ExAC
gnomAD
CA356661063
rs1578270476
RCV000999486
125 I>T No ClinGen
ClinVar
Ensembl
dbSNP
CA356661055
rs1405123351
127 T>P No ClinGen
gnomAD
rs111337616
CA356661018
132 V>F No ClinGen
TOPMed
CA2895158
rs771593403
132 V>G No ClinGen
ExAC
gnomAD
rs111337616
CA95713105
132 V>I No ClinGen
TOPMed
CA2895157
rs761454872
133 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs1439780087
CA356661006
134 V>A No ClinGen
gnomAD
rs1439780087
CA356661005
134 V>G No ClinGen
gnomAD
CA356661002
rs1182319939
135 R>Q No ClinGen
gnomAD
rs768674438
CA2895155
135 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA2895154
rs749259185
140 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs115137663
CA2895153
141 R>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs769545929
CA2895152
141 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA356660963
rs769545929
141 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs747242250
CA2895151
142 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs368044471
CA2895150
142 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA356660957
rs1355977627
143 I>V No ClinGen
gnomAD
rs1450410640
CA356660938
145 D>V No ClinGen
gnomAD
rs1381741430
CA356660930
146 A>G No ClinGen
gnomAD
rs752737840
CA2895147
148 T>A No ClinGen
ExAC
gnomAD
rs778991709
CA2895146
151 N>T No ClinGen
ExAC
gnomAD
rs754301626
CA2895144
154 L>F No ClinGen
ExAC
gnomAD
TCGA novel 154 L>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2895143
rs766757605
155 Q>R No ClinGen
ExAC
gnomAD
rs375062099
CA2895130
159 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs772235942
CA2895129
160 P>S No ClinGen
ExAC
gnomAD
CA356659482
rs1427070347
164 A>E No ClinGen
gnomAD
rs748387130
CA2895128
166 G>* No ClinGen
ExAC
gnomAD
rs755113560
CA2895126
167 T>I No ClinGen
ExAC
gnomAD
rs908289507
CA95712927
170 K>R No ClinGen
gnomAD
CA356659375
rs1288573479
171 D>N No ClinGen
gnomAD
CA2895123
rs756467468
175 P>T No ClinGen
ExAC
gnomAD
CA356659272
rs1305524531
176 D>E No ClinGen
gnomAD
CA356659277
rs1223728130
176 D>G No ClinGen
gnomAD
CA2895120
rs768014546
180 I>T No ClinGen
ExAC
gnomAD
CA2895119
rs527756813
182 G>R No ClinGen
1000Genomes
ExAC
gnomAD
CA95712918
rs948466547
185 T>I No ClinGen
TOPMed
CA356659129
rs1238738890
187 E>K No ClinGen
Ensembl
CA356659081
rs1282156495
189 Q>R No ClinGen
TOPMed
rs751260541
CA2895118
190 R>I No ClinGen
ExAC
TOPMed
gnomAD
rs751260541
CA356659070
190 R>K No ClinGen
ExAC
TOPMed
gnomAD
CA2895117
rs763685293
191 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs894232451
CA95712899
193 Q>* No ClinGen
TOPMed
CA356659027
rs1578269896
193 Q>R No ClinGen
Ensembl
rs1443799790
CA356659015
194 A>T No ClinGen
gnomAD
CA2895116
rs144192248
194 A>V No ClinGen
ESP
ExAC
gnomAD
rs1171919565
CA356658994
195 L>P No ClinGen
gnomAD
rs775468206
CA2895115
196 C>W No ClinGen
ExAC
gnomAD
CA356658957
rs1427393045
198 V>I No ClinGen
gnomAD
rs1463142555
CA356658911
200 E>D No ClinGen
TOPMed
CA356658893
rs765048353
201 H>Q No ClinGen
ExAC
TOPMed
gnomAD
CA356658899
rs1199000393
201 H>R No ClinGen
TOPMed
gnomAD
CA95712870
rs1054657510
203 V>I No ClinGen
TOPMed
rs933655472
CA356658828
205 R>K No ClinGen
gnomAD
CA95712862
rs933655472
205 R>T No ClinGen
gnomAD
rs778486297
CA95712841
206 E>G No ClinGen
TOPMed
CA2895112
rs776235593
208 I>F No ClinGen
ExAC
gnomAD
CA2895111
rs770721281
211 T>N No ClinGen
ExAC
gnomAD
rs1319762440
CA356658713
212 N>D No ClinGen
gnomAD
CA2895109
rs774610502
216 S>* No ClinGen
ExAC
gnomAD
rs879942832
CA95712459
222 A>T No ClinGen
Ensembl
CA95712457
rs566624969
222 A>V No ClinGen
Ensembl
CA356658593
rs1352368485
223 A>E No ClinGen
gnomAD
TCGA novel 226 F>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1450230376
CA356658560
228 A>S No ClinGen
TOPMed
rs1243008711
CA356658556
229 Q>K No ClinGen
gnomAD
CA356658521
rs1389035323
233 S>I No ClinGen
Ensembl
rs763881954
CA2895095
234 I>V No ClinGen
ExAC
gnomAD
rs1396973439
CA356658492
237 I>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA356658497
rs1333993203
237 I>V No ClinGen
TOPMed
gnomAD
CA95712449
rs200380906
239 A>G No ClinGen
Ensembl
CA356658478
rs1287358288
240 L>M No ClinGen
gnomAD
CA356658449
rs1453094335
244 T>A No ClinGen
gnomAD
rs1413039249
CA356658428
247 D>E No ClinGen
TOPMed
gnomAD
rs1457035532
CA356658432
247 D>N No ClinGen
gnomAD
rs139554286
CA2895092
247 D>V No ClinGen
ESP
ExAC
TOPMed
rs1159158609
CA356658398
252 A>T No ClinGen
gnomAD
rs759328854
CA2895089
257 M>K No ClinGen
ExAC
TOPMed
gnomAD
CA95712392
rs886950933
268 A>G No ClinGen
Ensembl
rs766146242
CA2895087
268 A>S No ClinGen
ExAC
gnomAD
rs760508476
CA2895086
269 S>N No ClinGen
ExAC
gnomAD
TCGA novel 275 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356658216
rs1129052
276 C>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1273664472
CA356658203
278 Q>R No ClinGen
TOPMed
gnomAD
rs1423831672
CA356658172
283 N>D No ClinGen
gnomAD
TCGA novel 285 V>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA95711904
rs985297316
288 C>Y No ClinGen
gnomAD
rs776883283
CA2895061
290 A>V No ClinGen
ExAC
gnomAD
rs199986130
CA2895060
298 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs968491131
CA95711895
298 R>H No ClinGen
TOPMed
gnomAD
CA356656284
rs1464295100
304 I>T No ClinGen
gnomAD
rs1239397498
CA356656301
304 I>V No ClinGen
gnomAD
CA356656215
rs1159032166
306 M>R No ClinGen
TOPMed
rs1333198828
CA356656127
309 Y>H No ClinGen
gnomAD
rs1317015589
CA356655982
313 R>K No ClinGen
TOPMed
TCGA novel 313 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs779173046
CA2895037
317 R>W No ClinGen
ExAC
gnomAD
TCGA novel 320 D>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356655653
COSM1195945
rs1578264977
325 T>I lung [Cosmic] No ClinGen
cosmic curated
Ensembl
CA356655581
rs1287204329
329 K>N No ClinGen
TOPMed
rs755687279
CA2895033
333 I>L No ClinGen
ExAC
gnomAD
CA356655529
rs1578264948
333 I>M No ClinGen
Ensembl
rs1027527120
CA95710366
333 I>S No ClinGen
Ensembl
CA95710361
rs973256107
335 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA95710358
rs764725337
339 K>R No ClinGen
Ensembl
rs1203959093
CA356655332
342 T>S No ClinGen
TOPMed
CA356655307
rs1283606237
344 D>N No ClinGen
TOPMed
rs1290408243
CA356655039
350 S>N No ClinGen
gnomAD
rs1260191836
RCV000999478
CA356654886
356 Y>* No ClinGen
ClinVar
TOPMed
dbSNP
CA95710156
rs917325637
358 M>L No ClinGen
Ensembl
rs1479782965
CA356654864
358 M>T No ClinGen
TOPMed
CA2895011
rs769271659
362 A>T No ClinGen
ExAC
gnomAD
rs10010387
CA2895009
363 H>R No ClinGen
ExAC
TOPMed
gnomAD
CA2895008
rs543523320
364 L>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs746926346
CA2895007
365 H>L No ClinGen
ExAC
gnomAD
CA356654816
rs1423124119
365 H>Q No ClinGen
gnomAD
TCGA novel 369 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 369 P>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1171698535
CA356654784
370 K>E No ClinGen
TOPMed
gnomAD
CA2895006
rs777622665
370 K>T No ClinGen
ExAC
gnomAD
CA95710143
rs937346725
374 E>K No ClinGen
Ensembl
rs1370929186
CA356654730
378 V>M No ClinGen
TOPMed
rs1461226039
CA356654708
381 S>Y No ClinGen
TOPMed
rs766743798
CA2895003
382 H>Q No ClinGen
ExAC
CA356654692
rs182948898
384 G>R No ClinGen
1000Genomes
gnomAD
CA95710135
rs182948898
384 G>S No ClinGen
1000Genomes
gnomAD
CA2895001
rs750465337
384 G>V No ClinGen
ExAC
gnomAD
rs372994324
CA2895000
385 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2894999
rs762313199
386 S>* No ClinGen
ExAC
gnomAD
CA356654658
rs1407273373
389 D>G No ClinGen
TOPMed
CA2894998
rs774785564
390 Q>H No ClinGen
ExAC
gnomAD
rs1481372223
CA356654580
393 R>Q No ClinGen
gnomAD
CA356654559
rs1420139288
394 L>P No ClinGen
gnomAD
rs752083244
CA2894980
395 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA2894978
rs763473129
399 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs763473129
CA356654465
399 K>T No ClinGen
ExAC
TOPMed
gnomAD
rs770011021
CA356654438
400 D>G No ClinGen
TOPMed
rs1238675111
CA356654451
400 D>N No ClinGen
TOPMed
gnomAD
rs770011021
CA95709797
400 D>V No ClinGen
TOPMed
TCGA novel 401 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs899094826
CA95709793
402 Y>H No ClinGen
TOPMed
rs778755178
CA95709787
404 A>T No ClinGen
Ensembl
CA2894977
rs753003368
406 D>G No ClinGen
ExAC
gnomAD
CA2894976
rs765591985
407 G>D No ClinGen
ExAC
TOPMed
gnomAD
CA356654295
rs1560686114
407 G>S No ClinGen
Ensembl
CA2894974
rs776207068
408 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA2894975
rs776207068
408 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs1051697509
CA95709770
413 I>V No ClinGen
Ensembl
CA356654099
rs1361014385
416 E>* No ClinGen
gnomAD
CA2894969
rs141970383
416 E>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 417 W>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs371662600
CA2894968
419 M>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs921785690
CA95709724
419 M>T No ClinGen
Ensembl
CA356654015
rs1437820312
419 M>V No ClinGen
gnomAD
rs141551091
CA95709719
COSM39271
420 F>S central_nervous_system skin [Cosmic] No ClinGen
cosmic curated
Ensembl
CA2894951
rs370295255
422 E>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2894952
rs772787684
422 E>K No ClinGen
ExAC
gnomAD
rs922278383
CA95709395
426 E>K No ClinGen
gnomAD
CA2894949
rs148161041
427 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2894948
rs768474926
427 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA356653848
rs148161041
427 R>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 429 H>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2894947
rs147122976
431 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs774133578 432 M>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 432 M>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1318866802
CA356653720
435 P>A No ClinGen
gnomAD
rs1162365973
CA356653687
437 F>S No ClinGen
gnomAD
CA356653695
rs1388307521
437 F>V No ClinGen
gnomAD
rs754871857
CA2894944
438 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA2894942
rs777823955
COSM221255
440 D>N haematopoietic_and_lymphoid_tissue [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1195945550
CA356653627
443 R>C No ClinGen
gnomAD
rs748628569
CA2894940
444 V>L No ClinGen
ExAC
gnomAD
CA95709367
rs903705209
447 G>E No ClinGen
Ensembl
CA356653571
rs1259165663
447 G>R No ClinGen
TOPMed
CA2894939
rs779324355
449 H>L No ClinGen
ExAC
TOPMed
gnomAD
rs137877647
CA95709355
450 N>S No ClinGen
ESP
TOPMed
gnomAD
CA95709360
rs137877647
450 N>T No ClinGen
ESP
TOPMed
gnomAD
CA356653506
rs1256363149
451 E>V No ClinGen
gnomAD
rs371132377
CA2894938
453 Q>* No ClinGen
ESP
ExAC
gnomAD
rs766784095
CA2894937
453 Q>H No ClinGen
ExAC
gnomAD
CA2894935
rs755764491
455 I>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs934953491
CA95709348
455 I>V No ClinGen
TOPMed
rs753344592
CA95709337
456 G>V No ClinGen
Ensembl
CA95707149
rs895364082
459 I>T No ClinGen
TOPMed
gnomAD
CA2894912
rs749809838
461 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA356651959
rs749809838
461 T>K No ClinGen
ExAC
TOPMed
gnomAD
CA2894911
rs749809838
461 T>R No ClinGen
ExAC
TOPMed
gnomAD
rs1048654784
CA95707144
462 I>V No ClinGen
TOPMed
gnomAD
CA356651757
rs750080424
466 V>L No ClinGen
ExAC
gnomAD
CA2894908
rs750080424
466 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA2894907
rs767319348
469 K>E No ClinGen
ExAC
TOPMed
gnomAD
CA356651668
rs767319348
469 K>Q No ClinGen
ExAC
TOPMed
gnomAD
rs757002418
CA2894905
472 P>A No ClinGen
ExAC
gnomAD
rs866070634
CA95707128
473 Y>C No ClinGen
Ensembl
rs1337082775
CA356651510
473 Y>H No ClinGen
TOPMed
CA2894904
rs146932231
475 P>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2894903
rs763664159
476 S>F No ClinGen
ExAC
gnomAD
CA2894902
rs760852204
477 G>S No ClinGen
ExAC
gnomAD
CA356651327
rs1279344897
479 I>F No ClinGen
gnomAD
CA2894900
rs764992651
480 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA2894901
rs775554067
480 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA356651278
rs775554067
480 P>T No ClinGen
ExAC
TOPMed
gnomAD
rs766650772
CA95707110
481 K>Q No ClinGen
Ensembl
rs1373738864
CA356651131
482 F>C No ClinGen
gnomAD
CA356651134
rs1239210469
482 F>V No ClinGen
gnomAD
rs1373738864
CA356651130
482 F>Y No ClinGen
gnomAD
CA356651074
rs1280951409
483 S>N No ClinGen
gnomAD
TCGA novel 485 Q>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 485 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1339369402
CA356650926
487 P>T No ClinGen
gnomAD
rs772229766
CA2894897
488 P>S No ClinGen
ExAC
gnomAD
CA2894896
rs762039752
489 N>K No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 491 K>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356650729
rs1359236936
491 K>R No ClinGen
gnomAD
CA356650694
rs1158537408
492 P>T No ClinGen
gnomAD

1 associated diseases with O60701

[MIM: 618792]: Developmental and epileptic encephalopathy 84 (DEE84)

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE84 is an autosomal recessive form characterized by onset of refractory seizures in the first months of life. {ECO:0000269|PubMed:32001716}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE84 is an autosomal recessive form characterized by onset of refractory seizures in the first months of life. {ECO:0000269|PubMed:32001716}. Note=The disease is caused by variants affecting the gene represented in this entry.

3 regional properties for O60701

Type Name Position InterPro Accession
domain UDP-glucose/GDP-mannose dehydrogenase, N-terminal 6 - 190 IPR001732
domain UDP-glucose/GDP-mannose dehydrogenase, dimerisation 214 - 308 IPR014026
domain UDP-glucose/GDP-mannose dehydrogenase, C-terminal 332 - 447 IPR014027

Functions

Description
EC Number 1.1.1.22 With NAD(+) or NADP(+) as acceptor
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

3 GO annotations of molecular function

Name Definition
identical protein binding Binding to an identical protein or proteins.
NAD binding Binding to nicotinamide adenine dinucleotide, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NAD+, or the reduced form, NADH.
UDP-glucose 6-dehydrogenase activity Catalysis of the reaction: H(2)O + 2 NAD(+) + UDP-alpha-D-glucose = 3 H(+) + 2 NADH + UDP-alpha-D-glucuronate.

8 GO annotations of biological process

Name Definition
carbohydrate metabolic process The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
chondroitin sulfate biosynthetic process The chemical reactions and pathways resulting in the formation of chondroitin sulfate, any member of a group of 10-60 kDa glycosaminoglycans, widely distributed in cartilage and other mammalian connective tissues, the repeat units of which consist of beta-(1,4)-linked D-glucuronyl beta-(1,3)-N-acetyl-D-galactosamine sulfate.
gastrulation with mouth forming second A gastrulation process in which the initial invagination becomes the anus and the mouth forms second.
glycosaminoglycan biosynthetic process The chemical reactions and pathways resulting in the formation of glycosaminoglycans, any of a group of polysaccharides that contain amino sugars.
heparan sulfate proteoglycan biosynthetic process The chemical reactions and pathways resulting in the formation of the heparan sulfate proteoglycan, a glycosaminoglycan with repeat unit consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues; the former are a mixture of sulfated and nonsulfated D-glucuronic acid and L-iduronic acid; the L-iduronic acid is either sulfated or acetylated on its amino group as well as being sulfated on one of its hydroxyl groups; heparan sulfate chains are covalently linked to peptidyl-serine by a glycosidic attachment through the trisaccharide galactosyl-galactosyl-xylosyl to serine residues.
neuron development The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
protein hexamerization The formation of a protein hexamer, a macromolecular structure consisting of six noncovalently associated identical or nonidentical subunits.
UDP-glucuronate biosynthetic process The chemical reactions and pathways resulting in the formation of UDP-glucuronate, a substance composed of glucuronic acid in glycosidic linkage with uridine diphosphate.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P12378 UGDH UDP-glucose 6-dehydrogenase Bos taurus (Bovine) PR
Q5F3T9 UGDH UDP-glucose 6-dehydrogenase Gallus gallus (Chicken) PR
O70475 Ugdh UDP-glucose 6-dehydrogenase Mus musculus (Mouse) PR
O70199 Ugdh UDP-glucose 6-dehydrogenase Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MFEIKKICCI GAGYVGGPTC SVIAHMCPEI RVTVVDVNES RINAWNSPTL PIYEPGLKEV
70 80 90 100 110 120
VESCRGKNLF FSTNIDDAIK EADLVFISVN TPTKTYGMGK GRAADLKYIE ACARRIVQNS
130 140 150 160 170 180
NGYKIVTEKS TVPVRAAESI RRIFDANTKP NLNLQVLSNP EFLAEGTAIK DLKNPDRVLI
190 200 210 220 230 240
GGDETPEGQR AVQALCAVYE HWVPREKILT TNTWSSELSK LAANAFLAQR ISSINSISAL
250 260 270 280 290 300
CEATGADVEE VATAIGMDQR IGNKFLKASV GFGGSCFQKD VLNLVYLCEA LNLPEVARYW
310 320 330 340 350 360
QQVIDMNDYQ RRRFASRIID SLFNTVTDKK IAILGFAFKK DTGDTRESSS IYISKYLMDE
370 380 390 400 410 420
GAHLHIYDPK VPREQIVVDL SHPGVSEDDQ VSRLVTISKD PYEACDGAHA VVICTEWDMF
430 440 450 460 470 480
KELDYERIHK KMLKPAFIFD GRRVLDGLHN ELQTIGFQIE TIGKKVSSKR IPYAPSGEIP
490
KFSLQDPPNK KPKV